{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T14:09:35Z","timestamp":1784038175166,"version":"3.55.0"},"reference-count":42,"publisher":"American Society of Hematology","issue":"13","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,7,14]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>Donor polymorphisms in killer-cell immunoglobulin-like receptor (KIR) and HLA shape natural killer (NK) cell activity, which may influence relapse risk after allogeneic hematopoietic stem cell transplantation (allo-HSCT). However, association studies have been limited by insufficient allele-level KIR genotyping. Using high-resolution, long-read genotyping of 15 KIR genes, we performed an unbiased discovery analysis in 219 patients with T-cell leukemia\/lymphoma (ATL) who underwent allo-HSCT to identify relapse-associated donor KIR\/HLA polymorphisms. We comprehensively tested associations between donor KIR\/HLA amino acid\u2013level combinations and relapse risk, accounting for linkage disequilibrium across KIR haplotypes, and validated the findings in independent cohorts. In ATL, KIR3DL1\u2217005 or KIR3DS1\u2217013 with glutamic acid at position 62 in the HLA-B \u03b12 domain (HLA-B-D2-62E) and KIR3DL1\u2217001\/\u2217007\/\u2217015\/\u2217020 with HLA-B-D2-62V (valine) were high-risk (H) combinations. Meanwhile, KIR3DL1\u2217015 with isoleucine at position 80 in the HLA-B \u03b11 domain (HLA-B-D1-80I) and KIR3DL1\u2217001\/\u2217005\/\u2217007\/\u2217020 with HLA-B-D1-80T (threonine) were low-risk (L) combinations. Compared with L-\/H+ donors (n = 119), L+\/H-, L-\/H-, and L+\/H+ donors (n = 80) showed reduced relapse (adjusted hazard ratio [HR], 0.36; 95% confidence interval [CI], 0.19-0.65; P = 7.5 \u00d7 10-4) and improved overall survival (adjusted HR, 0.67; 95% CI, 0.45-0.98; P = .038). Those donors were associated with reduced relapse in other T-cell malignancies (n = 145; adjusted HR, 0.37; 95% CI, 0.16-0.89; P = .026) but not in acute myeloid leukemia (n = 965; P = .77), suggesting disease specificity. Low-risk combinations increased CD107a degranulation of KIR3DL1+ NK cells against HLA class I\u2013deficient targets, consistent with enhanced NK cell education. These findings support KIR\/HLA-based donor selection and underscore the role of antitumor NK cell immunity.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1182\/bloodadvances.2025019066","type":"journal-article","created":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T14:55:54Z","timestamp":1776437754000},"page":"4563-4572","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":0,"title":["Long-read KIR genotyping reveals donor KIR\/HLA polymorphisms linked to posttransplant relapse in T-cell malignancies"],"prefix":"10.1182","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-5650-4969","authenticated-orcid":false,"given":"Mari","family":"Morita","sequence":"first","affiliation":[{"name":"1Center for Genomic Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan"},{"name":"2Department of Hematology, Graduate School of Medicine, Kyoto University, Kyoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4045-6518","authenticated-orcid":false,"given":"Shuji","family":"Kawaguchi","sequence":"additional","affiliation":[{"name":"1Center for Genomic Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2085-6151","authenticated-orcid":false,"given":"Takero","family":"Shindo","sequence":"additional","affiliation":[{"name":"2Department of Hematology, Graduate School of Medicine, Kyoto University, Kyoto, Japan"},{"name":"3Department of Hematology\/Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyotaka","family":"Izumi","sequence":"additional","affiliation":[{"name":"2Department of Hematology, Graduate School of Medicine, Kyoto University, Kyoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masakazu","family":"Shimizu","sequence":"additional","affiliation":[{"name":"1Center for Genomic Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichi","family":"Inadomi","sequence":"additional","affiliation":[{"name":"1Center for Genomic Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6704-3633","authenticated-orcid":false,"given":"Junya","family":"Kanda","sequence":"additional","affiliation":[{"name":"2Department of Hematology, Graduate School of Medicine, Kyoto University, Kyoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4030-4653","authenticated-orcid":false,"given":"Mizuki","family":"Watanabe","sequence":"additional","affiliation":[{"name":"2Department of Hematology, Graduate School of Medicine, Kyoto University, Kyoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiko","family":"Takahashi","sequence":"additional","affiliation":[{"name":"1Center for Genomic Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3281-0150","authenticated-orcid":false,"given":"Taro","family":"Tsujimura","sequence":"additional","affiliation":[{"name":"4Institute for the Advanced Study of Human Biology, Kyoto University, Kyoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-4111-6052","authenticated-orcid":false,"given":"Shoko","family":"Tarumoto","sequence":"additional","affiliation":[{"name":"4Institute for the Advanced Study of Human Biology, Kyoto University, Kyoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0022-3947","authenticated-orcid":false,"given":"Takuya","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"4Institute for the Advanced Study of Human Biology, Kyoto University, Kyoto, Japan"},{"name":"5Center for iPS Cell Research and Application, Kyoto University, Kyoto, Japan"},{"name":"6Medical-risk Avoidance based on iPS Cells Team, RIKEN Center for Advanced Intelligence Project, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Kato","sequence":"additional","affiliation":[{"name":"7Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidenori","family":"Tanaka","sequence":"additional","affiliation":[{"name":"8HLA Foundation Laboratory, Kyoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7391-4271","authenticated-orcid":false,"given":"Satoko","family":"Morishima","sequence":"additional","affiliation":[{"name":"9Central Japan Cord Blood Bank, Seto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuo","family":"Morishima","sequence":"additional","affiliation":[{"name":"9Central Japan Cord Blood Bank, Seto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9826-7616","authenticated-orcid":false,"given":"Nobuaki","family":"Nakano","sequence":"additional","affiliation":[{"name":"10Department of Hematology, Imamura General Hospital, Kagoshima, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayasu","family":"Hayashi","sequence":"additional","affiliation":[{"name":"11Department of Hematology, Hamanomachi Hospital, Fukuoka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiko","family":"Miyazaki","sequence":"additional","affiliation":[{"name":"12Department of Hematology, Oita Prefectural Hospital, Oita, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazunori","family":"Imada","sequence":"additional","affiliation":[{"name":"13Department of Hematology, Japanese Red Cross Osaka Hospital, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-4888-3777","authenticated-orcid":false,"given":"Yusuke","family":"Higuchi","sequence":"additional","affiliation":[{"name":"14Department of Hematology, National Hospital Organization Kumamoto Medical Center, Kumamoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihito","family":"Yonezawa","sequence":"additional","affiliation":[{"name":"15Department of Hematology, Kokura Memorial Hospital, Kitakyushu, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youko","family":"Suehiro","sequence":"additional","affiliation":[{"name":"16Department of Hematology and Cell Therapy, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5935-0385","authenticated-orcid":false,"given":"Makoto","family":"Yoshimitsu","sequence":"additional","affiliation":[{"name":"17Department of Hematology and Rheumatology, Kagoshima University Hospital, Kagoshima, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8661-3179","authenticated-orcid":false,"given":"Noriko","family":"Doki","sequence":"additional","affiliation":[{"name":"18Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5054-9104","authenticated-orcid":false,"given":"Yuta","family":"Katayama","sequence":"additional","affiliation":[{"name":"19Department of Hematology, Hiroshima Red Cross Hospital and Atomic-bomb Survivors Hospital, Hiroshima, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuta","family":"Hasegawa","sequence":"additional","affiliation":[{"name":"20Department of Hematology, Hokkaido University Hospital, Sapporo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kentaro","family":"Serizawa","sequence":"additional","affiliation":[{"name":"21Division of Hematology and Rheumatology, Department of Internal Medicine, Kindai University Hospital, Osakasayama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0393-4066","authenticated-orcid":false,"given":"Tatsuo","family":"Ichinohe","sequence":"additional","affiliation":[{"name":"3Department of Hematology\/Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Fukuda","sequence":"additional","affiliation":[{"name":"22Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3864-0823","authenticated-orcid":false,"given":"Makoto","family":"Onizuka","sequence":"additional","affiliation":[{"name":"23Department of Hematology\/Oncology, Tokai University School of Medicine, Isehara, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4404-2870","authenticated-orcid":false,"given":"Yoshiko","family":"Atsuta","sequence":"additional","affiliation":[{"name":"24Japanese Data Center for Hematopoietic Cell Transplantation, Nagakute, Japan"},{"name":"25Department of Registry Science for Transplant and Cellular Therapy, Aichi Medical University School of Medicine, Nagakute, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7678-4284","authenticated-orcid":false,"given":"Akifumi","family":"Takaori-Kondo","sequence":"additional","affiliation":[{"name":"2Department of Hematology, Graduate School of Medicine, Kyoto University, Kyoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4557-4553","authenticated-orcid":false,"given":"Fumihiko","family":"Matsuda","sequence":"additional","affiliation":[{"name":"1Center for Genomic Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2026,6,26]]},"reference":[{"issue":"7","key":"2026071409574978700_bib1","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1038\/s41375-023-01924-x","article-title":"Allogeneic hematopoietic stem cell transplantation for NK\/T-cell lymphoma: an international collaborative analysis","volume":"37","author":"Berning","year":"2023","journal-title":"Leukemia"},{"issue":"9","key":"2026071409574978700_bib2","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1038\/s41409-024-02300-8","article-title":"Prognostic factors impacting post-transplant outcomes in adult T-cell acute lymphoblastic leukemia: a registry-based study by the EBMT Acute Leukemia Working Party","volume":"59","author":"El Cheikh","year":"2024","journal-title":"Bone Marrow Transpl"},{"issue":"8","key":"2026071409574978700_bib3","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1182\/blood-2009-10-247510","article-title":"Transplantation of allogeneic hematopoietic stem cells for adult T-cell leukemia: a nationwide retrospective study","volume":"116","author":"Hishizawa","year":"2010","journal-title":"Blood"},{"issue":"1","key":"2026071409574978700_bib4","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/s41409-020-00996-y","article-title":"GVHD-free, relapse-free survival provides novel clues for optimizing allogeneic-HSCT for adult T-cell leukemia\/lymphoma","volume":"56","author":"Muranushi","year":"2021","journal-title":"Bone Marrow Transpl"},{"issue":"12","key":"2026071409574978700_bib5","doi-asserted-by":"crossref","first-page":"4567","DOI":"10.1111\/cas.14658","article-title":"Prognosis of patients with adult T-cell leukemia\/lymphoma in Japan: a nationwide hospital-based study","volume":"111","author":"Imaizumi","year":"2020","journal-title":"Cancer Sci"},{"issue":"11","key":"2026071409574978700_bib6","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1038\/ng.3415","article-title":"Integrated molecular analysis of adult T cell leukemia\/lymphoma","volume":"47","author":"Kataoka","year":"2015","journal-title":"Nat Genet"},{"issue":"10","key":"2026071409574978700_bib7","doi-asserted-by":"crossref","first-page":"2998","DOI":"10.1038\/s41375-021-01403-1","article-title":"Full-length HLA sequencing in adult T cell leukemia-lymphoma uncovers multiple gene alterations","volume":"35","author":"Tamaki","year":"2021","journal-title":"Leukemia"},{"issue":"5","key":"2026071409574978700_bib8","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/s41568-021-00339-z","article-title":"Antigen presentation in cancer: insights into tumour immunogenicity and immune evasion","volume":"21","author":"Jhunjhunwala","year":"2021","journal-title":"Nat Rev Cancer"},{"issue":"6055","key":"2026071409574978700_bib9","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/319675a0","article-title":"Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy","volume":"319","author":"K\u00e4rre","year":"1986","journal-title":"Nature"},{"issue":"8","key":"2026071409574978700_bib10","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1200\/JCO.2011.37.3472","article-title":"Defucosylated anti-CCR4 monoclonal antibody (KW-0761) for relapsed adult T-cell leukemia-lymphoma: a multicenter phase II study","volume":"30","author":"Ishida","year":"2012","journal-title":"J Clin Oncol"},{"issue":"3","key":"2026071409574978700_bib11","doi-asserted-by":"crossref","first-page":"eaag1672","DOI":"10.1126\/sciimmunol.aag1672","article-title":"Class I HLA haplotypes form two schools that educate NK cells in different ways","volume":"1","author":"Horowitz","year":"2016","journal-title":"Sci Immunol"},{"issue":"2","key":"2026071409574978700_bib12","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nri3370","article-title":"Variable NK cell receptors and their MHC class I ligands in immunity, reproduction and human evolution","volume":"13","author":"Parham","year":"2013","journal-title":"Nat Rev Immunol"},{"issue":"25","key":"2026071409574978700_bib13","doi-asserted-by":"crossref","first-page":"5182","DOI":"10.1182\/blood-2009-07-231977","article-title":"Significant functional heterogeneity among KIR2DL1 alleles and a pivotal role of arginine 245","volume":"114","author":"Bari","year":"2009","journal-title":"Blood"},{"issue":"7","key":"2026071409574978700_bib14","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1084\/jem.20020304","article-title":"The D0 domain of KIR3D acts as a major histocompatibility complex class I binding enhancer","volume":"196","author":"Khakoo","year":"2002","journal-title":"J Exp Med"},{"issue":"2","key":"2026071409574978700_bib15","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.immuni.2006.06.013","article-title":"Human NK cell education by inhibitory receptors for MHC class I","volume":"25","author":"Anfossi","year":"2006","journal-title":"Immunity"},{"issue":"5562","key":"2026071409574978700_bib16","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1126\/science.1068440","article-title":"Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants","volume":"295","author":"Ruggeri","year":"2002","journal-title":"Science"},{"issue":"20","key":"2026071409574978700_bib17","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1200\/JCO.2016.70.7059","article-title":"KIR3DL1\/HLA-B subtypes govern acute myelogenous leukemia relapse after hematopoietic cell transplantation","volume":"35","author":"Boudreau","year":"2017","journal-title":"J Clin Oncol"},{"issue":"9","key":"2026071409574978700_bib18","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1056\/NEJMoa1200503","article-title":"HLA-C-dependent prevention of leukemia relapse by donor activating KIR2DS1","volume":"367","author":"Venstrom","year":"2012","journal-title":"N Engl J Med"},{"issue":"8","key":"2026071409574978700_bib19","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.bbmt.2006.05.007","article-title":"The effect of KIR ligand incompatibility on the outcome of unrelated donor transplantation: a report from the center for international blood and marrow transplant research, the European blood and marrow transplant registry, and the Dutch registry","volume":"12","author":"Farag","year":"2006","journal-title":"Biol Blood Marrow Transpl"},{"issue":"16","key":"2026071409574978700_bib20","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1182\/blood.2019002887","article-title":"External validation of models for KIR2DS1\/KIR3DL1-informed selection of hematopoietic cell donors fails","volume":"135","author":"Schetelig","year":"2020","journal-title":"Blood"},{"issue":"3","key":"2026071409574978700_bib21","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/ng.1076","article-title":"Five amino acids in three HLA proteins explain most of the association between MHC and seropositive rheumatoid arthritis","volume":"44","author":"Raychaudhuri","year":"2012","journal-title":"Nat Genet"},{"key":"2026071409574978700_bib22","doi-asserted-by":"crossref","first-page":"5902","DOI":"10.1038\/ncomms6902","article-title":"The HLA-DR\u03b21 amino acid positions 11-13-26 explain the majority of SLE-MHC associations","volume":"5","author":"Kim","year":"2014","journal-title":"Nat Commun"},{"issue":"11","key":"2026071409574978700_bib23","doi-asserted-by":"crossref","first-page":"e2004199118","DOI":"10.1073\/pnas.2004199118","article-title":"Genome wide association study of HTLV-1-associated myelopathy\/tropical spastic paraparesis in the Japanese population","volume":"118","author":"Penova","year":"2021","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"2026071409574978700_bib24","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s12185-015-1894-x","article-title":"Introduction of Transplant Registry Unified Management Program 2 (TRUMP2): scripts for TRUMP data analyses, part I (variables other than HLA-related data)","volume":"103","author":"Atsuta","year":"2016","journal-title":"Int J Hematol"},{"issue":"10","key":"2026071409574978700_bib25","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1007\/s00251-005-0048-3","article-title":"High-throughput DNA typing of HLA-A, -B, -C, and -DRB1 loci by a PCR-SSOP-Luminex method in the Japanese population","volume":"57","author":"Itoh","year":"2005","journal-title":"Immunogenetics"},{"issue":"7","key":"2026071409574978700_bib26","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1182\/blood-2014-10-604785","article-title":"Biological significance of HLA locus matching in unrelated donor bone marrow transplantation","volume":"125","author":"Morishima","year":"2015","journal-title":"Blood"},{"issue":"7","key":"2026071409574978700_bib27","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1002\/humu.23230","article-title":"HLA-HD: an accurate HLA typing algorithm for next-generation sequencing data","volume":"38","author":"Kawaguchi","year":"2017","journal-title":"Hum Mutat"},{"issue":"13","key":"2026071409574978700_bib28","doi-asserted-by":"crossref","first-page":"4576","DOI":"10.1182\/blood-2007-06-097386","article-title":"High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation","volume":"110","author":"Lee","year":"2007","journal-title":"Blood"},{"issue":"3","key":"2026071409574978700_bib29","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.bbmt.2008.12.497","article-title":"Reduced-intensity conditioning regimen workshop: defining the dose spectrum. Report of a workshop convened by the center for international blood and marrow transplant research","volume":"15","author":"Giralt","year":"2009","journal-title":"Biol Blood Marrow Transpl"},{"issue":"6","key":"2026071409574978700_bib30","first-page":"825","article-title":"1994 consensus conference on acute GVHD grading","volume":"15","author":"Przepiorka","year":"1995","journal-title":"Bone Marrow Transpl"},{"issue":"12","key":"2026071409574978700_bib31","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.bbmt.2005.09.004","article-title":"National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and Staging Working Group report","volume":"11","author":"Filipovich","year":"2005","journal-title":"Biol Blood Marrow Transpl"},{"issue":"7","key":"2026071409574978700_bib32","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1002\/gepi.20408","article-title":"A new measure of the effective number of tests, a practical tool for comparing families of non-independent significance tests","volume":"33","author":"Galwey","year":"2009","journal-title":"Genet Epidemiol"},{"issue":"4","key":"2026071409574978700_bib33","doi-asserted-by":"crossref","first-page":"e10207","DOI":"10.1371\/journal.pone.0010207","article-title":"The textile plot: a new linkage disequilibrium display of multiple-single nucleotide polymorphism genotype data","volume":"5","author":"Kumasaka","year":"2010","journal-title":"PLoS One"},{"issue":"8","key":"2026071409574978700_bib34","doi-asserted-by":"crossref","first-page":"687","DOI":"10.4049\/immunohorizons.2100054","article-title":"KIR3DL1 allotype-dependent modulation of NK cell immunity against chronic myeloid leukemia","volume":"5","author":"Izumi","year":"2021","journal-title":"Immunohorizons"},{"issue":"3","key":"2026071409574978700_bib35","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1084\/jem.181.3.1133","article-title":"The Bw4 public epitope of HLA-B molecules confers reactivity with natural killer cell clones that express NKB1, a putative HLA receptor","volume":"181","author":"Gumperz","year":"1995","journal-title":"J Exp Med"},{"issue":"4","key":"2026071409574978700_bib36","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/ng934","article-title":"Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS","volume":"31","author":"Martin","year":"2002","journal-title":"Nat Genet"},{"issue":"3","key":"2026071409574978700_bib37","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1182\/blood.2024024817","article-title":"Genetic alteration of class I HLA in cutaneous T-cell lymphoma","volume":"145","author":"Kwang","year":"2025","journal-title":"Blood"},{"issue":"7","key":"2026071409574978700_bib38","doi-asserted-by":"crossref","first-page":"4238","DOI":"10.4049\/jimmunol.1001494","article-title":"Coevolution of killer cell Ig-like receptors with HLA-C to become the major variable regulators of human NK cells","volume":"185","author":"Older Aguilar","year":"2010","journal-title":"J Immunol"},{"issue":"4","key":"2026071409574978700_bib39","doi-asserted-by":"crossref","first-page":"849","DOI":"10.4049\/jimmunol.2001109","article-title":"The role of the HLA class I \u03b12 helix in determining ligand hierarchy for the killer cell Ig-like receptor 3DL1","volume":"206","author":"Saunders","year":"2021","journal-title":"J Immunol"},{"issue":"17","key":"2026071409574978700_bib40","doi-asserted-by":"crossref","first-page":"3455","DOI":"10.1182\/blood-2012-03-416867","article-title":"CD8 T cells express randomly selected KIRs with distinct specificities compared with NK cells","volume":"120","author":"Bj\u00f6rkstr\u00f6m","year":"2012","journal-title":"Blood"},{"issue":"29","key":"2026071409574978700_bib41","doi-asserted-by":"crossref","first-page":"eaao2892","DOI":"10.1126\/sciimmunol.aao2892","article-title":"Inhibitory killer cell immunoglobulin-like receptors strengthen CD8+ T cell-mediated control of HIV-1, HCV, and HTLV-1","volume":"3","author":"Boelen","year":"2018","journal-title":"Sci Immunol"},{"issue":"1","key":"2026071409574978700_bib42","doi-asserted-by":"crossref","first-page":"5350","DOI":"10.1038\/s41467-019-13113-5","article-title":"Missing self triggers NK cell-mediated chronic vascular rejection of solid organ transplants","volume":"10","author":"Koenig","year":"2019","journal-title":"Nat Commun"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/10\/13\/4563\/2530531\/blooda_adv-2025-019066-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/10\/13\/4563\/2530531\/blooda_adv-2025-019066-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T13:57:56Z","timestamp":1784037476000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/10\/13\/4563\/567832\/Long-read-KIR-genotyping-reveals-donor-KIR-HLA"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,26]]},"references-count":42,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2026,7,14]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2025019066","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,7,14]]},"published":{"date-parts":[[2026,6,26]]}}}